KSB represents Glenmark Pharmaceuticals in acquisition of Medicamenta
Glenmark Pharmaceuticals Ltd. is the Indian leader in the development of newmolecules in mainly inflammation and metabolic disorders. The company operatesin more than eighty countries worldwide and the acquisition of Medicamenta a.s.represents a strategic entry into two of the fastest growing markets in the EU.
Other articles
KŠB advises Olpran in Bikero insolvency proceedings
Kocián Šolc Balaštík has advised bicycle manufacturer Olpran, a notable player in the Czech cycling market, in the insolvency proceedings of Bikero.
European Commission Proposes Transforming EUSPA into European Union Space Services Agency
On April 7, 2026, the European Commission published a proposal for a regulation establishing the European Union Space Services Agency (EUSSA), amending Regulation (EU) 2021/696. The proposal [COM(2026) 152 final] significantly expands the mandate of the existing EUSPA, headquartered in Prague, and nearly doubles its budget.
